Level Four Advisory Services, LLC Viking Therapeutics, Inc. Transaction History
Level Four Advisory Services, LLC
- $2.29 Billion
- Q4 2024
A detailed history of Level Four Advisory Services, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 7,402 shares of VKTX stock, worth $234,125. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,402
Previous 7,228
2.41%
Holding current value
$234,125
Previous $457,000
35.01%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding VKTX
# of Institutions
466Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$322 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$191 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$156 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$82 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$68.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.43B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...